Solarea Bio

Solarea Bio

Edit info

  • Founded: 2017
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Funding: $15M B May 2023; $11.2M A Oct 2020
  • Investors: S2G Ventures, Bold Capital Partners, Viking Global Investors, GG 1978 SICAF SIF


solareabio.com

linkedin.com


About:

Solarea Bio is unlocking a new source of microbes that can be used to improve human health. Foods containing probiotics can be applied to treat inflammatory processes including the gut-musculoskeletal axis. Using their powerful computational engine, Solarea is combining microbial discovery and genomics to rapidly deliver safe and effective medical food products to address chronic inflammatory conditions. Solarea’s first application aims to address the metabolic processes of osteopenia and osteoporosis in postmenopausal women where diet alone is not sufficient to maintain a healthy skeleton.Therefore, by understanding the interactions between the human body and microbes in food, Solarea is advancing food as medicine.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com